Glucocorticoid-mediated inhibition of angiogenic changes in human endothelial cells is not caused by reductions in cell proliferation or migration

• Published in: PloS one 2010-12, Vol.5 (12), p.e14476
• Main Authors: Logie, James J, Ali, Sadaf, Marshall, Kathryn M, Heck, Margarete M S, Walker, Brian R, Hadoke, Patrick W F
• Format: Article
• Language: English
• Subjects: Angiogenesis; Aorta; Aorta - cytology; Blood vessels; Bromodeoxyuridine - pharmacology; Cardiovascular Disorders/Cardiovascular Pharmacology; Cardiovascular Disorders/Vascular Biology; Cell adhesion & migration; Cell morphology; Cell Movement; Cell Proliferation; Cell Survival; Cellular manufacture; Cellular structure; Collagen - chemistry; Cortisol; Cytokines; Cytology; Cytoskeleton; Dexamethasone; Diabetes; Diabetes and Endocrinology/Endocrinology; Drug Combinations; Endothelial cells; Endothelial Cells - cytology; Endothelium; Glucocorticoid receptors; Glucocorticoids; Glucocorticoids - chemistry; Heart attacks; Humans; Hydrocortisone - metabolism; Inhibition; Laboratories; Laminin - chemistry; Medical research; Mifepristone - pharmacology; Neovascularization; Neovascularization, Pathologic; Physiology; Proteoglycans - chemistry; Receptors; Reverse Transcriptase Polymerase Chain Reaction; Science; Steroids (Organic compounds); Thrombospondin 1 - biosynthesis; Umbilical vein; Umbilical Veins - cytology; Vascular endothelial growth factor; Viability; Wound healing
• ISSN: 1932-6203; 1932-6203
• DOI: 10.1371/journal.pone.0014476

Glucocorticoid-mediated inhibition of angiogenesis is important in physiology, pathophysiology and therapy. However, the mechanisms through which glucocorticoids inhibit growth of new blood vessels have not been established. This study addresses the hypothesis that physiological levels of glucocorticoids inhibit angiogenesis by directly preventing tube formation by endothelial cells. Cultured human umbilical vein (HUVEC) and aortic (HAoEC) endothelial cells were used to determine the influence of glucocorticoids on tube-like structure (TLS) formation, and on cellular proliferation (5-bromo-2'-deoxyuridine (BrdU) incorporation), viability (ATP production) and migration (Boyden chambers). Dexamethasone or cortisol (at physiological concentrations) inhibited both basal and prostaglandin F(2α) (PGF(2α))-induced and vascular endothelial growth factor (VEGF) stimulated TLS formation in endothelial cells (ECs) cultured on Matrigel, effects which were blocked with the glucocorticoid receptor antagonist RU38486. Glucocorticoids had no effect on EC viability, migration or proliferation. Time-lapse imaging showed that cortisol blocked VEGF-stimulated cytoskeletal reorganisation and initialisation of tube formation. Real time PCR suggested that increased expression of thrombospodin-1 contributed to glucocorticoid-mediated inhibition of TLS formation. We conclude that glucocorticoids interact directly with glucocorticoid receptors on vascular ECs to inhibit TLS formation. This action, which was conserved in ECs from two distinct vascular territories, was due to alterations in cell morphology rather than inhibition of EC viability, migration or proliferation and may be mediated in part by induction of thrombospodin-1. These findings provide important insights into the anti-angiogenic action of endogenous glucocorticoids in health and disease.